EricMBonnemMD

PubMed

• 19 citations
  Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.
  Gregory J. Dehmer, Richard A. Lange, David A. Tate, Mark J. Pirwitz, William C. Daniel, Melrose Fisher, Eric M. Bonnem> ;Circulation. 1996 Nov 1
• 21 citations
  Phase I trial of recombinant platelet factor 4 (rPF4) in patients with advanced colorectal carcinoma.
  Neil Belman, Eric M. Bonnem, Harold A. Harvey, Allan Lipton> ;Investigational New Drugs. 1996 Jan 1
• 34 citations
  Reversal of Heparin Anticoagulation by Recombinant Platelet Factor 4 in Humans
  Gregory J. Dehmer, Melrose Fisher, David A. Tate, Steve Teo, Eric M. Bonnem> ;Circulation. 1995 Apr 15
• Phase I trial of m-BACOD and granulocyte macrophage colony stimulating factor in HIV-associated non-Hodgkin's lymphoma.
  Walsh, C., Wernz, J. C., Levine, A., Rarick, M., Willson, E., Melendez, D., Bonnem, E., Thompson, J., Shelton, B.> ;J Acquir Immune Defic Syndr. 1993 Mar
• Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex.
  Hewitt, R. G., Morse, G. D., Lawrence, W. D., Maliszewski, M. L., Santora, J., Bartos, L., Bonnem, E., Poiesz, B.> ;Antimicrob Agents Chemother. 1993 Mar
• Recombinant human interleukin 4 (IL-4) given as daily subcutaneous injections--a phase I dose toxicity trial.
  Gilleece, M. H., Scarffe, J. H., Ghosh, A., Heyworth, C. M., Bonnem, E., Testa, N., Stern, P., Dexter, T. M.> ;Br J Cancer. 1992 Jul
• Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.
  Advani, R., Chao, N. J., Horning, S. J., Blume, K. G., Ahn, D. K., Lamborn, K. R., Fleming, N. C., Bonnem, E. M., Greenberg, P. L.> ;Ann Intern Med. 1992 Feb 1
• Low Dose Interferon Alfa-2B for the Induction of Remission of Hairy Cell Leukemia: A Multi-institutional Study of 49 Patients.
  Golomb HM, Ratain MJ, Fefer A, Thompson J, Portlock CS, Ozer H, Mick R, Chiavello J, Israel RJ, Bonnem EM> ;Leuk. Lymphoma. 1991-01-01
• Survival Experience of 195 Patients with Hairy Cell Leukemia Treated in a Multi-Institutional Study with Interferon-Alfa 2B.
  Golomb HM, Fefer A, Golde DW, Ozer H, Portlock C, Silber R, Rappeport J, Ratain MJ, Thompson J, Bonnem E, Spiegel R, Tensen L, Burke JS, Vardiman JW> ;Leuk. Lymphoma. 1991-01-01
• alpha Interferon: the potential drug of adjuvant therapy: past achievements and future challenges.
  Bonnem, E. M.> ;Eur J Cancer. 1991
• High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma.
  Barlogie, B., Jagannath, S., Dixon, D. O., Cheson, B., Smallwood, L., Hendrickson, A., Purvis, J. D., Bonnem, E., Alexanian, R.> ;Blood. 1990 Aug 15
• Granulocyte-macrophage colony stimulating factor (GM-CSF) after high-dose melphalan in patients with advanced colon cancer.
  Steward, W. P., Scarffe, J. H., Dirix, L. Y., Chang, J., Radford, J. A., Bonnem, E., Crowther, D.> ;Br J Cancer. 1990 May
• Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration.
  Lieschke, G. J., Maher, D., O'Connor, M., Green, M., Sheridan, W., Rallings, M., Bonnem, E., Burgess, A. W., McGrath, K., Fox, R. M.> ;Cancer Res. 1990 Feb 1
• Clinical studies with recombinant human granulocyte-macrophage colony-stimulating factor.
  Steward, W. P., Scarffe, J. H., Bonnem, E., Crowther, D.> ;Int J Cell Cloning. 1990 Jan
• GM-CSF with ganciclovir for the treatment of CMV retinitis in AIDS.
  Grossberg, H. S., Bonnem, E. M., Buhles, W. C.> ;N Engl J Med. 1989 Jun 8
• 140 citations
  Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects
  John A. Thompson, Douglas J. Lee, Pamela Kidd, E Rubin, Jenny Kaufmann, Eric M. Bonnem, Alexander Fefer> ;Journal of Clinical Oncology. 1989 May 1
• 158 citations
  Effects of bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy.
  Graham J. Lieschke, Darryl W. Maher, Jonathan Cebon, M O'Connor, Michael D. Green, William P. Sheridan, Andrew W. Boyd, Michael Rallings, Eric Bonnem, Donald Metcalf, ...> ;Annals of Internal Medicine. 1989 Mar 1
• Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.
  Steward, W. P., Scarffe, J. H., Austin, R., Bonnem, E., Thatcher, N., Morgenstern, G., Crowther, D.> ;Br J Cancer. 1989 Jan
• 10 citations
  Phase I-II Trial of Interferon-α2b by Continuous Subcutaneous Infusion over 28 Days
  Robert T. Dorr, Sydney E. Salmon, Aurelia Robertone, Eric Bonnem> ;Journal of Interferon Research. 1988 Dec 1
• A prospective randomized trial of alpha 2B-interferon/gamma-interferon or the combination in advanced metastatic renal cell carcinoma.
  Foon, K., Doroshow, J., Bonnem, E., Fefer, A., Graham, S., Grosh, B., Narayan, P., Elias, L., Harvey, H., Schulof, R.> ;J Biol Response Mod. 1988 Dec
• Pharmacokinetics of human granulocyte-macrophage colony-stimulating factor using a sensitive immunoassay.
  Cebon, J., Dempsey, P., Fox, R., Kannourakis, G., Bonnem, E., Burgess, A. W., Morstyn, G.> ;Blood. 1988 Oct
• Phase I study of recombinant gamma-interferon (rIFN-gamma).
  Boman, B. M., Gagen, M. M., Bonnem, E., Ajani, J. A., Schmidt, S., Dimery, I. W., Golando, J., Neidhart, J.> ;J Biol Response Mod. 1988 Oct
• Report of a multi-institutional study of 193 patients with hairy cell leukemia treated with interferon-alfa2b.
  Golomb, H. M., Fefer, A., Golde, D. W., Ozer, H., Portlock, C., Silber, R., Rappeport, J., Ratain, M. J., Thompson, J., Bonnem, E.> ;Semin Oncol. 1988 Oct
• Granulocyte macrophage colony stimulating factor (GM-CSF) current status and future development.
  Bonnem, E. M., Morstyn, G.> ;Semin Oncol. 1988 Oct
• Randomized study of the duration of treatment with interferon alfa-2B in patients with hairy cell leukemia.
  Golomb, H. M., Ratain, M. J., Fefer, A., Thompson, J., Golde, D. W., Ozer, H., Portlock, C., Silber, R., Rappeport, J., Bonnem, E.> ;J Natl Cancer Inst. 1988 May 4
• Join now to see all